Resultaten visas 1 - 10 / 11074
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Fecal microbiome alterations in treatment-naive de novo Parkinson's disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-022-00395-8
PPNN Study Group; Boertien, Jeffrey M.; Murtomäki, Kirsi; Pereira, Pedro A. B.; van der Zee, Sygrid;...
npj parkinson's disease2022Publicationer information ikon

A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson's disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-022-00436-2
Borghammer, Per; Just, Mie Kristine; Horsager, Jacob; Skjaerbaek, Casper; Raunio, Anna; Kok, Eloise ...
npj parkinson's disease2022Publicationer information ikon

Endoplasmic Reticulum Stress Regulators:New Drug Targets for Parkinson's Disease

Referentgranskad
Öppen tillgång
DOI
10.3233/jpd-212673
Kovaleva, Vera; Saarma, Mart
Journal of Parkinson's disease2021Publicationer information ikon

Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson's disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-022-00300-3
Pereira, Pedro A. B.; Trivedi, Drupad K.; Silverman, Justin; Duru, Ilhan Cem; Paulin, Lars; Auvinen,...
npj parkinson's disease2022Publicationer information ikon

GDNF and Parkinson's Disease:Where Next? A Summary from a Recent Workshop

Referentgranskad
Öppen tillgång
DOI
10.3233/JPD-202004
Barker, Roger A.; Björklund, Anders; Gash, Don M.; Whone, Alan; Laar, Amber Van; Kordower, Jeffrey H...
Journal of Parkinson's disease2020Publicationer information ikon

Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop

Öppen tillgång
DOI
10.1177/1877718x241301041
Barker, Roger A.; Saarma, Mart; Svendsen, Clive N.; Morgan, Catherine; Whone, Alan; Fiandaca, Massim...
Journal of Parkinson's disease2024Publicationer information ikon

Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-024-00701-6
Sauerbier, Anna; Herberg, Johanna; Stopic, Vasilija; Loehrer, Philipp A.; Ashkan, Keyoumars; Rizos, ...
npj parkinson's disease2024Publicationer information ikon

Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-021-00174-x
EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease...
npj parkinson's disease2021Publicationer information ikon

Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-021-00260-0
van Kessel, Sebastiaan P.; Auvinen, Petri; Scheperjans, Filip; El Aidy, Sahar
npj parkinson's disease2021Publicationer information ikon

Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats

Referentgranskad
Öppen tillgång
DOI
10.3233/JPD-202400
Renko, Juho-Matti; Mahato, Arun Kumar; Visnapuu, Tanel; Valkonen, Konsta; Karelson, Mati; Voutilaine...
Journal of Parkinson's disease2021

Fecal microbiome alterations in treatment-naive de novo Parkinson's disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-022-00395-8
2022

A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson's disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-022-00436-2
2022

Endoplasmic Reticulum Stress Regulators:New Drug Targets for Parkinson's Disease

Referentgranskad
Öppen tillgång
DOI
10.3233/jpd-212673
2021

Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson's disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-022-00300-3
2022

GDNF and Parkinson's Disease:Where Next? A Summary from a Recent Workshop

Referentgranskad
Öppen tillgång
DOI
10.3233/JPD-202004
2020

Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop

Öppen tillgång
DOI
10.1177/1877718x241301041
2024

Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-024-00701-6
2024

Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-021-00174-x
2021

Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease

Referentgranskad
Öppen tillgång
DOI
10.1038/s41531-021-00260-0
2021

Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats

Referentgranskad
Öppen tillgång
DOI
10.3233/JPD-202400
2021